Navigation Links
Stopping smallpox in its tracks: A new anti-viral approach

Natural or deliberate exposure to smallpox poses a great health threat, especially since routine smallpox vaccinations have been discontinued and no clinically approved treatment currently exists. In the February 1 issue of the Journal of Clinical Investigation, Ellis Reinherz and colleagues from Harvard Medical School propose a new antiviral therapy ?a low molecular weight inhibitor of signaling mediated by the smallpox growth factor (SPGF).


SPGF targets the erbB-1 signaling molecule, which normally initiates an intracellular cascade that facilitates viral replication. This study shows that drugs that interfere with erbB-1 signaling inhibit SPGF-induced viral replication and spread. The authors show that treatment with these erbB-1 inhibitors are effective in lowering morbidity and mortality, and boosting T cell immunity, in infected mice.

In an accompanying commentary, Anthony Fauci and Mark Challberg from the National Institutes of Health point out that this approach "may serve to turn the tables on the virus by interfering with the very pathways that are required for viral replication and extrusion."

This study demonstrates, for the first time, that chemical inhibition of host cell signaling pathways exploited by infectious agents represents a new avenue for development of anti-viral therapeutics. These inhibitors, which are already in use in human anti-tumor therapy, may have widespread applications in human viral infections and protection from smallpox. These findings reveal a new approach to the identification and development of antiviral compounds. This is especially critical at a time when the threat of smallpox as a biological weapon is high.


'"/>

Source:Journal of Clinical Investigation


Page: 1

Related biology news :

1. Menopause Symptoms May Come Back After Stopping Menopausal Hormone Therapy
2. Stopping plants from getting sick
3. Secret of smallpoxs success may lead to bioterror cure
4. LIAI scientists make major finding on potential smallpox treatment
5. Researchers develop new testing methods for potential monkeypox or smallpox outbreak
6. Serious adverse reactions to smallpox vaccine appear to be limited
7. Mice studies illustrate potential of chimp/human antibodies to protect against smallpox
8. Defective immune system response to smallpox vaccine detailed in new study
9. Mass vaccination unnecessary in the event of a large bioterrorist US smallpox attack
10. Web model of influenza-host lifecycles will aid scientists in creating anti-viral drugs
11. Using natures most primitive anti-viral defense system to find new approaches to cancer research
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/15/2016)... April 15, 2016 Research ... Gait Biometrics Market 2016-2020,"  report to their offering.  ... ) , ,The global gait biometrics market is ... during the period 2016-2020. Gait analysis ... can be used to compute factors that are ...
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys has ... CEO, Barrett Bready , M.D., who returned to ... the original technical leadership team, including Chief Technology Officer, ... Product Development, Steve Nurnberg and Vice President of Software ... the company. Dr. Bready served as CEO ...
Breaking Biology News(10 mins):
(Date:5/19/2016)... 19, 2016 - I dati ... durante il 52 ° Congresso ... - Le conclusioni dello studio indicano un ... trattati, di cui il 90% presenta una d urata ... più. Il settantadue per cento dei pazienti ha riscontrato un ...
(Date:5/18/2016)... ... 18, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... assault kit processing to help them save time and reduce errors. , Sexual Assault ... be processed and victims informed of results. Due to a previous lack of tools, ...
(Date:5/17/2016)... Haselmeier announces the launch by ... by EMA, the European Medicines Agency. Originally launched in ... the new pen version includes enhancements to further improve ... to patients during use. Its enhanced design ... handle with a larger display window that improves the ...
(Date:5/17/2016)... ... , ... The Children’s Tumor Foundation is enthusiastic to announce that in honor ... support in the fight against neurofibromatosis (NF) by lighting up blue and green, the ... tumors to grow on nerves throughout the body. It affects 1 in 3,000 people ...
Breaking Biology Technology: